Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
J Agric Food Chem ; 72(12): 6613-6624, 2024 Mar 27.
Article in English | MEDLINE | ID: mdl-38501445

ABSTRACT

Propaquizafop is a highly efficient aryloxy phenoxy propionate chiral herbicide. However, the use of propaquizafop, including its safe use methods, residue patterns, dietary risk assessment, and maximum residue limits, for ginseng, a traditional Chinese medicinal plant, has not been studied. An analytical method was established for the simultaneous determination of propaquizafop and its four metabolites in ginseng soil, fresh ginseng, ginseng plant, and dried ginseng using HPLC-MS/MS. This approach showed good linearity (R2 ranging from 0.9827 to 0.9999) and limit of quantification ranging from 0.01 to 0.05 mg/kg. The intra- and interday recovery rates of this method ranged from 71.6 to 107.1% with relative standard deviation ranging from 1.3 to 23.2%. The method was applied to detect residual samples in the field, and it was found that the degradation of propaquizafop in ginseng plants and soil followed a first-order kinetic equation. R2 was between 0.8913 and 0.9666, and the half-life (t1/2) ranged from 5.04 to 8.05 days, indicating that it was an easily degradable pesticide (T1/2 < 30 days). The final propaquizafop residues in ginseng soil, plants, fresh ginseng, and dried ginseng ranged from 0.017 to 0.691 mg/kg. A dietary risk assessment was conducted on the final propaquizafop residue in fresh and dried ginseng. The results showed that the chronic exposure risk quotient values were less than 100% for fresh and dried ginseng (1.15% for fresh ginseng and 1.13% for dried ginseng). This illustrates that the dietary risk associated with the use of 10% propaquizafop emulsifiable concentrate in ginseng is very low. Thus, applying 750 mL/ha of propaquizafop on ginseng could not pose an unacceptable risk to public health. The results of the present study support the registration of propaquizafop in ginseng.


Subject(s)
Panax , Pesticide Residues , Soil Pollutants , Tandem Mass Spectrometry/methods , Panax/chemistry , Pesticide Residues/analysis , Soil Pollutants/chemistry , Risk Assessment , Half-Life , Soil/chemistry , China
2.
Front Neurol ; 14: 1151660, 2023.
Article in English | MEDLINE | ID: mdl-37396767

ABSTRACT

Traumatic brain injury (TBI) is the leading cause for high morbidity and mortality rates in young adults, survivors may suffer from long-term physical, cognitive, and/or psychological disorders. Establishing better models of TBI would further our understanding of the pathophysiology of TBI and develop new potential treatments. A multitude of animal TBI models have been used to replicate the various aspects of human TBI. Although numerous experimental neuroprotective strategies were identified to be effective in animal models, a majority of strategies have failed in phase II or phase III clinical trials. This failure in clinical translation highlights the necessity of revisiting the current status of animal models of TBI and therapeutic strategies. In this review, we elucidate approaches for the generation of animal models and cell models of TBI and summarize their strengths and limitations with the aim of exploring clinically meaningful neuroprotective strategies.

3.
Front Pharmacol ; 14: 1185533, 2023.
Article in English | MEDLINE | ID: mdl-37475717

ABSTRACT

Traumatic brain injury (TBI) has become one of the most important causes of death and disability worldwide. A series of neuroinflammatory responses induced after TBI are key factors for persistent neuronal damage, but at the same time, such inflammatory responses can also promote debris removal and tissue repair after TBI. The concept of pleiotropic neuroprotection delves beyond the single-target treatment approach, considering the multifaceted impacts following TBI. This notion embarks deeper into the research-oriented treatment paradigm, focusing on multi-target interventions that inhibit post-TBI neuroinflammation with enhanced therapeutic efficacy. With an enriched comprehension of TBI's physiological mechanisms, this review dissects the advancements in developing pleiotropic neuroprotective pharmaceuticals to mitigate TBI. The aim is to provide insights that may contribute to the early clinical management of the condition.

4.
Medicine (Baltimore) ; 102(25): e34009, 2023 Jun 23.
Article in English | MEDLINE | ID: mdl-37352020

ABSTRACT

Neuroinflammation after traumatic brain injury (TBI) is related to chronic neurodegenerative diseases and is one of the causes of acute secondary injury after TBI. Therefore, it is particularly important to clarify the role of cellular mechanisms in the neuroinflammatory response after TBI. The objective of this article is to understand the involvement of cells during the TBI inflammatory response (for instance, astrocytes, microglia, and oligodendrocytes) and shed light on the recent progress in the stimulation and interaction of granulocytes and lymphocytes, to provide a novel approach for clinical research. We searched articles in PubMed published between 1950 and 2023, using the following keywords: TBI, neuroinflammation, inflammatory cells, neuroprotection, clinical. Articles for inclusion in this paper were finalized based on their novelty, representativeness, and relevance to the main arguments of this review. We found that the neuroinflammatory response after TBI includes the activation of glial cells, the release of inflammatory mediators in the brain, and the recruitment of peripheral immune cells. These inflammatory responses not only induce secondary brain damage, but also have a role in repairing the nervous system to some extent. However, not all of the mechanisms of cell-to-cell interactions have been well studied. After TBI, clinical treatment cannot simply suppress the inflammatory response, and the inflammatory phenotype of patients' needs to be defined according to their specific conditions after injury. Clinical trials of personalized inflammation regulation therapy for specific patients should be carried out in order to improve the prognosis of patients.


Subject(s)
Brain Injuries, Traumatic , Brain Injuries , Animals , Mice , Neuroinflammatory Diseases , Brain Injuries, Traumatic/complications , Brain , Inflammation/complications , Brain Injuries/complications , Mice, Inbred C57BL
5.
Sci Rep ; 13(1): 5814, 2023 Apr 10.
Article in English | MEDLINE | ID: mdl-37037846

ABSTRACT

Propaquizafop is a fatty acid synthetic herbicide used to control annual and perennial grasses. To understand the potential environmental risks of propaquizafop to crops and food safety, the adsorption, mobility, and degradation of propaquizafop in five different soils were studied. At an initial concentration of 5 mg L-1 propaquizafop, its adsorption equilibrium was reached within 24 h, and the adsorption rates were between 46.98 and 57.76%. The Elovich kinetic model provided the best fit for the kinetic model, with R2 values between 0.9882 and 0.9940. For the isothermal adsorption tests, the Freundlich model was used to better fit the adsorption characteristics of propaquizafop in different soils, with R2 values between 0.9748 and 0.9885. Increasing the concentration of Ca2+ was beneficial for propaquizafop adsorption. In the soil thin-layer chromatography tests, the Rf of propaquizafop in the five soil samples ranged from 0.076 to 0.123. The results of the soil column leaching tests showed that propaquizafop did not migrate in the five soil columns; it was not detected in the leachate of each soil column, and propaquizafop in the soil columns only existed in the 0-5 cm soil layer. The results of soil thin-layer chromatography and soil column leaching tests showed that propaquizafop is a pesticide with a weak migration ability. Under the same environmental conditions, the degradation rate of propaquizafop in different soils followed the order LF fluvo-aquic soil (T1/2 = 1.41 d) > CS red loam (T1/2 = 2.76 d) > SX paddy soil (T1/2 = 3.52 d) > CC black soil (T1/2 = 5.74 d) > BS ginseng soil (T1/2 = 7.75 d). Considering the effects of soil moisture, incubation temperature, and microorganisms on propaquizafop degradation in the soil, temperature was found to have the greatest influence on its degradation rate.

6.
Molecules ; 27(23)2022 Dec 02.
Article in English | MEDLINE | ID: mdl-36500554

ABSTRACT

In this study, the quick, easy, cheap, effective, rugged, and safe (QuEChERS) method, combined with high-performance liquid chromatography−tandem mass spectrometry, was chosen for detecting pydiflumetofen residues in soybean plants, soybeans and soil, and assessing the risk of short- and long-term dietary intake. Pydiflumetofen concentrations ranging from 0.001−0.5 mg/L exhibited good linearity (r > 0.997). At varying doses, the average pydiflumetofen recovery rates and relative standard deviations among soybean plants, soybeans, and soil ranged from 83.9 ± 1.1% to 99.5 ± 3.3% and from 0.77 to 7.77%, respectively. The sensitivity, accuracy, and precision of the chosen methodology met the requirements of pesticide residue analysis. The results of the degradation dynamics test showed that the half-life of pydiflumetofen (t1/2) in soybean plants and in soil were 3.6 to 5.7 and from 7.9 to 25.7 d, respectively. Assessment of the concentration of pydiflumetofen residues in soybeans revealed acute and chronic dietary exposure risks of 0.06 and 7.54%, respectively. As these values are very low, pydiflumetofen residues in soybeans present an acceptable risk to public health. The results of this study will help to guide the practical application of pydiflumetofen and minimize the environmental risks associated with its use.


Subject(s)
Pesticide Residues , Tandem Mass Spectrometry , Tandem Mass Spectrometry/methods , Glycine max/chemistry , Pesticide Residues/analysis , Soil/chemistry , Risk Assessment , Half-Life
7.
J Funct Biomater ; 13(4)2022 Nov 08.
Article in English | MEDLINE | ID: mdl-36412871

ABSTRACT

Congenital disease, tumors, infections, and trauma are the main reasons for cranial bone defects. Herein, poly (butylene succinate) (PB)/silicon nitride (Si3N4) nanocomposites (PSC) with Si3N4 content of 15 w% (PSC15) and 30 w% (PSC30) were fabricated for cranial bone repair. Compared with PB, the compressive strength, hydrophilicity, surface roughness, and protein absorption of nanocomposites were increased with the increase in Si3N4 content (from 15 w% to 30 w%). Furthermore, the cell adhesion, multiplication, and osteoblastic differentiation on PSC were significantly enhanced with the Si3N4 content increasing in vitro. PSC30 exhibited optimized physicochemical properties (compressive strength, surface roughness, hydrophilicity, and protein adsorption) and cytocompatibility. The m-CT and histological results displayed that the new bone formation for SPC30 obviously increased compared with PB, and PSC30 displayed proper degradability (75.3 w% at 12 weeks) and was gradually replaced by new bone tissue in vivo. The addition of Si3N4 into PB not only optimized the surface performances of PSC but also improved the degradability of PSC, which led to the release of Si ions and a weak alkaline environment that significantly promoted cell response and tissue regeneration. In short, the enhancements of cellular responses and bone regeneration of PSC30 were attributed to the synergism of the optimized surface performances and slow release of Si ion, and PSC30 were better than PB. Accordingly, PSC30, with good biocompatibility and degradability, displayed a promising and huge potential for cranial bone construction.

8.
Int J Nanomedicine ; 15: 9389-9405, 2020.
Article in English | MEDLINE | ID: mdl-33262594

ABSTRACT

INTRODUCTION: Polyimide (PI) exhibits good biocompatibility and high mechanical strength, but biological inertness that does not stimulate bone regeneration, while laponite possesses excellent bioactivity. METHODS: In this study, to improve the bioactivity of PI, nano-laponite ceramic (LC)-PI composites (LPCs) were fabricated by melt processing as implantable materials for bone repair. RESULTS: The compressive strength, hydrophilicity, and surface roughness of LPCs with 40 w% LC content (LPC40s) were higher than LPC20s, and LPC20s higher than pure PI. In addition, no apatite mineralization occurred on PI, while apatite mineralized on LPCs in simulated body fluid. Compared with LPC20, more apatite deposited on LPC40, indicating good bioactivity. Moreover, the adhesion, proliferation, and alkaline phosphatase activity of rat bone mesenchymal stem cells on LPCs significantly increased with LC content increasing in vitro. Furthermore, the evaluations of animal experiments (micro-CT, histology, and pushout load) revealed that compared with LPC20 and PI, LPC40 significantly enhanced osteogenesis and osseointegration in vivo. DISCUSSION: Incorporation of LC into PI obviously improved not only surface physicochemical properties but also biological properties of LPCs. LPC40 with high LC content displayed good biocompatibility and bioactivity, which markedly promoted osteogenesis and osseointegration. Therefore, with its superior biocompatibility and bioactivity, LPC40 could be an alternative candidate as an implant for orthopedic applications.


Subject(s)
Apatites/metabolism , Biocompatible Materials/pharmacology , Ceramics/chemistry , Imides/chemistry , Osseointegration/drug effects , Silicates/chemistry , Silicates/pharmacology , Animals , Biocompatible Materials/chemistry , Bone Regeneration/drug effects , Cell Adhesion/drug effects , Cell Proliferation/drug effects , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/drug effects , Nanostructures/chemistry , Osteogenesis/drug effects , Rats , Surface Properties
9.
Sci Rep ; 10(1): 18509, 2020 10 28.
Article in English | MEDLINE | ID: mdl-33116163

ABSTRACT

The potential therapeutic effects of molecular hydrogen (H2) have now been confirmed in various human and animal-disease models. However, the effects of H2 on the physiological function in a normal state have been largely neglected. Hydrogen-rich water (HRW) intake and hydrogen inhalation (HI) are the most common used methods for hydrogen administration, the difference in the effects between HRW intake and HI remains elusive. In the present study, the body weight and 13 serum biochemical parameters were monitored during the six-month hydrogen intervention, all these parameters were significantly altered by oral intake of HRW or HI. Among the 13 parameters, the most striking alterations induced by hydrogen treatment were observed in serum myocardial enzymes spectrum. The results also showed that the changes in these parameters occurred at different time points, and the alterations in most of the parameters were much more significant in HI than HRW. The results of this study provides the basic data for the mechanism research and application of molecular hydrogen in the future.


Subject(s)
Hydrogen/pharmacology , Rats/physiology , Animals , Blood Glucose/drug effects , Body Weight/drug effects , China , Disease Models, Animal , Heart/drug effects , Hydrogen/administration & dosage , Hydrogen/metabolism , Liver/metabolism , Male , Myocardium/metabolism , Oxidative Stress/drug effects , Rats, Sprague-Dawley , Triglycerides/analysis , Uric Acid/analysis , Uric Acid/blood , Water/chemistry
10.
Int J Nanomedicine ; 15: 7279-7295, 2020.
Article in English | MEDLINE | ID: mdl-33061381

ABSTRACT

PURPOSE: A bioactive and degradable scaffold of ternary composite with good biocompatibility and osteogenesis was developed for bone tissue repair. MATERIALS AND METHODS: Polybutylene succinate (PS:50 wt%), magnesium phosphate (MP:40 wt%) and wheat protein (WP:10 wt%) composite (PMWC) scaffold was fabricated, and the biological performances of PMWC were evaluated both in vitro and vivo in this study. RESULTS: PMWC scaffold possessed not only interconnected macropores (400 µm to 600 µm) but also micropores (10 µm ~20 µm) on the walls of macropores. Incorporation of MP into composite improved the apatite mineralization (bioactivity) of PMWC scaffold in simulated body fluid (SBF), and addition of WP into composite further enhanced the degradability of PMWC in PBS compared with the scaffold of PS (50 wt%)/MP (50 wt%) composite (PMC) and PS alone. In addition, the PMWC scaffold containing MP and WP significantly promoted the proliferation and differentiation of mouse pre-osteoblastic cell line (MC3T3-E1) cells. Moreover, the images from synchrotron radiation microcomputed tomography (SRmCT) and histological sections of the in vivo implantation suggested that the PMWC scaffold containing MP and WP prominently improved the new bone formation and ingrowth compared with PMC and PS. Furthermore, the immunohistochemical analysis further confirmed that the PMWC scaffold obviously promoted osteogenesis and vascularization in vivo compared with PMC and PS. CONCLUSION: This study demonstrated that the biocompatible PMWC scaffold with improved bioactivity and degradability significantly promoted the osteogenesis and vascularization in vivo, which would have a great potential to be applied for bone tissue repair.


Subject(s)
Apatites/chemistry , Osteogenesis/physiology , Plant Proteins/chemistry , Tissue Scaffolds/chemistry , Animals , Apatites/metabolism , Bone Regeneration , Butylene Glycols/chemistry , Cell Differentiation/drug effects , Cell Line , Magnesium Compounds/chemistry , Male , Materials Testing , Mice , Osteoblasts/drug effects , Osteogenesis/drug effects , Phosphates/chemistry , Plant Proteins/metabolism , Polymers/chemistry , Rabbits , Triticum/chemistry , X-Ray Microtomography
11.
Brain Res ; 1748: 147053, 2020 12 01.
Article in English | MEDLINE | ID: mdl-32814064

ABSTRACT

Traumatic brain injury (TBI) is a major cause of mortality and disability worldwide. To date, therapies to treat any forms of TBI are still limited. Recent studies have demonstrated the potential neuroprotective effects of molecular hydrogen on TBI. Although it has been demonstrated that hydrogen inhalation (HI) for about 5 hrs immediately after TBI has a beneficial effect on brain injury, the most effective intervention procedure in the treatment of TBI remains unknown. The mechanism underlying the neuroprotective effects of HI on TBI also needs to be further investigated. Our results showed that inhalation of 4% hydrogen during the first day after TBI was the most effective hydrogen intervention procedure in the treatment of TBI. Pathological examination showed that HI could attenuate TBI-induced reactive astrocytosis and microglial activation. Nissl staining demonstrated a significant decrease in the number of nissl-stained dark neurons (N-DNs) in HI group compared to TBI group at 2 h post-TBI, and the TBI-induced neuronal loss was attenuated by HI at day 3 post-TBI. IHC staining showed that HI resulted a decrease in CD16-positive cells and a further increase in CD206-positive cells as compared to TBI group. Multiplex cytokine assay demonstrated the most profound regulatory effects induced by HI on the levels of IL-12, IFN-γ, and GM-CSF at 24 h post-TBI, which confirmed the inhibitory effect of hydrogen on microglia activation. We concluded that inhalation of 4% hydrogen during the first day after TBI was the most effective intervention procedure in the treatment of TBI. Our results also showed that hydrogen may exert its protective effects on TBI via inhibition of microglia activation and neuroinflammation.


Subject(s)
Brain Injuries, Traumatic/metabolism , Brain/drug effects , Hydrogen/pharmacology , Inflammation/metabolism , Microglia/drug effects , Neuroprotective Agents/pharmacology , Animals , Brain/metabolism , Brain/pathology , Brain Injuries, Traumatic/drug therapy , Brain Injuries, Traumatic/pathology , Disease Models, Animal , Hydrogen/therapeutic use , Inflammation/drug therapy , Inflammation/pathology , Male , Microglia/metabolism , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Neuroprotective Agents/therapeutic use , Rats , Rats, Sprague-Dawley , Signal Transduction/drug effects
12.
Plant Dis ; 103(6): 1213-1219, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30964418

ABSTRACT

To provide a high-throughput, efficient, and accurate method to monitor multiple-fungicide resistance of Botrytis cinerea in the field, we used the suspension array, sequencing, and mycelial growth assay in our research. Discriminating-dose bioassays for detecting carbendazim, diethofencarb, boscalid, and iprodione resistance (CarR, DieR, BosR, and IprR, respectively) were used to analyze 257 isolates collected from Hebei Province in China during 2016 and 2017. High resistance frequencies to carbendazim (100%), diethofencarb (92.08%), and iprodione (86.59%) were detected. BosR isolates accounted for 11.67% of the total. In addition, 103 isolates were randomly selected for phenotype and genotype detection. The high-throughput suspension array was utilized to detect eight genotypes simultaneously, including BenA-E198, BenA-198A, SdhB-H272, SdhB-272Y, BcOS1-I365, BcOS1-365S, erg27-F412, and erg27-412S, which were associated with resistance toward carbendazim or diethofencarb, boscalid, iprodione, and fenhexamid (FenR), respectively. Most of the benzimidazole-resistant isolates (81.55%) possessed the E198V mutation in the BenA gene. Ninety-three isolates with dual resistance to carbendazim and diethofencarb showed the E198V/K mutation. All BosR isolates carried the H272R mutation in the SdhB gene. The I365S and Q369P+N373S (66.99%) mutations in the BcOS1 gene were more frequently observed. No mutation was detected in the erg27 gene in Hebei isolates. There were 13 resistance profile phenotypes. Phenotypes with triple resistance were the most common (83.50%), and CarRDieRBosSIprRFenS was the major type. CarR isolates that carried E198V/K/A were all highly resistant (HR) and only one F200Y mutant was moderately resistant (MR) to carbendazim. Isolates that possessed E198V/K were MR or HR to diethofencarb. BosR isolates that possessed H272R mutation were lowly resistant (LR). IprR isolates were all LR or MR. The distribution of half maximal effective concentrations of CarR isolates with E198V/K mutations and IprR isolates with Q369P+N373S mutations significantly increased from 2016 to 2017. Combined with our observations, a combination method of the high-throughput suspension array and the mycelial growth assay was suggested to accurately monitor multiple resistance of B. cinerea in the field.


Subject(s)
Botrytis , Drug Resistance, Fungal , Fungicides, Industrial , Biological Assay , Botrytis/drug effects , Botrytis/growth & development , China , Drug Resistance, Fungal/genetics , Fungicides, Industrial/pharmacology , Genes, Fungal/genetics
13.
Int J Nanomedicine ; 13: 3883-3896, 2018.
Article in English | MEDLINE | ID: mdl-30013342

ABSTRACT

INTRODUCTION: It is predicted that with increased life expectancy in the whole world, there will be a greater demand for synthetic biomedical materials to repair or regenerate lost, injured or diseased tissues. Natural polymers, as biomedical materials, have been widely applied in the field of regenerative medicine. MATERIALS AND METHODS: By incorporation of nanoporous diopside bioglass (nDPB) into glia-din (GL) matrix, macro-nanoporous scaffolds of nDPB/GL composites (DGC) were fabricated by method of solution compressing and particles leaching. RESULTS: The results revealed that the DGC scaffolds possessed well-interconnected macropores of 200-500 µm and nanopores of 4 nm, and the porosity and degradability of DGC scaffolds remarkably increased with the increase in nDPB content. In addition, in vitro cell experiments revealed that the adhesion and growth of MC3T3-E1 cells on DGC scaffolds were significantly promoted, which depended on nDPB content. Moreover, the results of histological evaluations confirmed that the osteogenic properties and degradability of DGC scaffolds in vivo significantly improved, which were nDPB content dependent. Furthermore, the results of immunohistochemical analysis demonstrated that, with the increase in nDPB content, the type I collagen expression in DGC scaffolds in vivo obviously enhanced, indicating excellent osteogenesis. DISCUSSION AND CONCLUSION: The results demonstrated that the DGC scaffolds containing 30 wt% nDPB (30nDGC) exhibited good biocompatibility and new bone formation ability, which might have a great potential for applications in bone regeneration.


Subject(s)
Biocompatible Materials/pharmacology , Gliadin/chemistry , Nanopores , Osteogenesis/drug effects , Silicic Acid/pharmacology , Tissue Scaffolds/chemistry , Animals , Cell Adhesion , Cell Line , Cell Proliferation , Collagen Type I/metabolism , Humans , Mice , Nanopores/ultrastructure , Spectroscopy, Fourier Transform Infrared
14.
Cell Death Dis ; 9(5): 575, 2018 05 01.
Article in English | MEDLINE | ID: mdl-29760381

ABSTRACT

It is well known that induction of hepatocyte senescence could inhibit the development of hepatocellular carcinoma (HCC). Until now, it is still unclear how the degree of liver injury dictates hepatocyte senescence and carcinogenesis. In this study, we investigated whether the severity of injury determines cell fate decisions between hepatocyte senescence and carcinogenesis. After testing of different degrees of liver injury, we found that hepatocyte senescence is strongly induced in the setting of severe acute liver injury. Longer-term, moderate liver injury, on the contrary did not result into hepatocyte senescence, but led to a significant incidence of HCC instead. In addition, carcinogenesis was significantly reduced by the induction of severe acute injury after chronic moderate liver injury. Meanwhile, immune surveillance, especially the activations of macrophages, was activated after re-induction of senescence by severe acute liver injury. We conclude that severe acute liver injury leads to hepatocyte senescence along with activating immune surveillance and a low incidence of HCC, whereas chronic moderate injury allows hepatocytes to proliferate rather than to enter into senescence, and correlates with a high incidence of HCC. This study improves our understanding in hepatocyte cell fate decisions and suggests a potential clinical strategy to induce senescence to treat HCC.


Subject(s)
Carcinoma, Hepatocellular/metabolism , Cellular Senescence , Hepatocytes/metabolism , Liver Neoplasms/metabolism , Liver/injuries , Liver/metabolism , Acute Disease , Animals , Carcinoma, Hepatocellular/pathology , Hepatocytes/pathology , Liver/pathology , Liver Neoplasms/pathology , Mice , Mice, Knockout
15.
Spine (Phila Pa 1976) ; 42(18): 1355-1361, 2017 Sep 15.
Article in English | MEDLINE | ID: mdl-28187067

ABSTRACT

STUDY DESIGN: A dissection-based study of 10 fresh-frozen human cadavers. OBJECTIVE: The objective of this study was to identify and describe the radiating extraforaminal ligaments in the exit regions of the L1-L5 intervertebral foramina and to research their possible clinical significance. SUMMARY OF BACKGROUND DATA: The transforaminal ligaments at the L1-L5 intervertebral foramina have been well studied. However, detailed descriptions of the radiating extraforaminal ligaments at L1-L5 are lacking. METHODS: Eighty L1-L5 intervertebral foramina from 10 fresh cadavers were studied, and the extraforaminal ligaments were identified. The quantity, morphology, origin, insertion, and spatial orientation of the extraforaminal ligaments in the L1-L5 regions were examined. The length, width, diameter, and thickness of the ligaments were measured using a vernier caliper. RESULTS: A total of 224 extraforaminal ligaments were identified in the 80 L1-L5 intervertebral foramina, and the occurrence rate of extraforaminal ligaments was 100%. One hundred and eighteen (52.68%) of the extraforaminal ligaments were radiating ligaments, and 106 (47.32%) of the extraforaminal ligaments were transforaminal ligaments. There were 97 (43.30%) ligaments at the superior aspect of the exit regions of the intervertebral foramina, 51 (22.77%) ligaments at the anterior aspect, 44 (19.64%) ligaments at the inferior aspect, and 32 (14.29%) ligaments at the posterior aspect. The morphologies of the extraforaminal ligaments were divided into two types: the strap type and the trabs type. CONCLUSION: Radiating extraforaminal ligaments exist between spinal nerves and nearby structures. Radiating extraforaminal ligaments may be of clinical importance to surgeons. Dissecting the radiating extraforaminal ligaments before percutaneous endoscopic lumbar discectomy may be an important step in reducing postoperative pain, which may result in significant benefits for patients. LEVEL OF EVIDENCE: 3.


Subject(s)
Ligaments/anatomy & histology , Lumbar Vertebrae/anatomy & histology , Dissection , Humans , Ligaments/surgery , Lumbar Vertebrae/surgery
16.
Biomaterials ; 31(30): 7620-30, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20656346

ABSTRACT

Efficacious hemostatic agents have significant potential for use in rapid exsanguinating hemorrhage control by emergency medical technician or military medic nowadays. Unfortunately, the topical hemostats currently available in market still have various disadvantages. In this study, a series of macroporous chitosan coated mesoporous silica xerogel beads (CSSX) with good biocompatibility were developed. They consisted of mesoporous silica xerogel cores and chitosan layers with macroporous structure by using modified sol-gel process and PEG molecular imprinting technique. The textural properties of the CSSX beads were optimized by in vitro and in vivo evaluation for promoting blood clotting and the results indicated that the prepared CSSX beads can significantly accelerate the contact activation pathway of coagulation cascade and produce desirable hemostasis, with the best efficiency from the CSSX prepared with 2% chitosan and 5% PEG. Furthermore, these CSSX beads were observed to create no exothermic reaction and the subsequential tissue thermal injury by histological examination, and exhibited no obvious cytotoxicity even after 7 days. The results of the present study forward CSSX bead as a safe hemostatic system and present a platform for further optimization studies of materials with enhanced hemostatic capabilities for specific injury types.


Subject(s)
Chitosan/chemistry , Coated Materials, Biocompatible , Gels , Hemorrhage/drug therapy , Hemostatics/chemistry , Molecular Imprinting , Silicon Dioxide/chemistry , Animals , Cell Line , Coated Materials, Biocompatible/chemistry , Coated Materials, Biocompatible/therapeutic use , Femoral Artery/pathology , Gels/chemistry , Gels/therapeutic use , Hemostasis , Humans , Materials Testing , Mice , Microscopy, Electron, Scanning , Porosity , Rabbits
17.
Biomed Mater ; 5(3): 35004, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20404401

ABSTRACT

This study aims to investigate the interaction between calcium silicate/calcium phosphate cement (CS/CPC) and osteogenesis, in particular the in vitro osteoblast-like and endothelial cells' response to CS/CPC. The effect of CS/CPC on cell attachment, proliferation and differentiation of murine osteoblast-like cell MC3T3-E1, as well as the influence on the cell attachment and proliferation of human umbilical vein endothelial cell (HUVEC), was studied in detail. Our results indicated that CS/CPC exhibited excellent biocompatibility to the osteoblast-like cells. Moreover, the morphology and cytoskeleton organization of MC3T3-E1 cultured on the CS/CPC disks suggested that CS/CPC induced better cell adhesion and cell spreading. Simultaneously, cell proliferation and alkaline phosphatase (ALP) activity of MC3T3-E1 were significantly improved after 3 and 7 days of culture on CS/CPC disks in comparison with CPC disks. Additionally, on CS/CPC disks, HUVEC attached well on day 1 and cell proliferation was also greatly enhanced by day 7. Collectively, these results suggest that the introduction of calcium silicate may improve the cell response involved in the osteogenesis and thus may be beneficial to further modify CPC as a better bone repairing material.


Subject(s)
Bone Cements/pharmacology , Calcium Phosphates/pharmacology , Endothelial Cells/metabolism , Osteoblasts/cytology , Osteoblasts/drug effects , Silicates/pharmacology , Bone Cements/metabolism , Calcium/metabolism , Calcium Phosphates/metabolism , Calcium, Dietary/metabolism , Calcium, Dietary/pharmacology , Cell Adhesion , Cell Differentiation/drug effects , Cell Proliferation , Humans , Osteoblasts/metabolism , Osteogenesis/drug effects , Silicates/metabolism
18.
Di Yi Jun Yi Da Xue Xue Bao ; 22(7): 650-2, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12376303

ABSTRACT

OBJECTIVE: To compare the differences in glycyrrhizic acid contents of Gegenqinlian decoctions (a traditional Chinese herbal preparation) prepared according to varied prescription, so as to establish a referential standard for controlling the acid level in such preparations. METHODS: Reverse phase-high performance liquid chromatography (RP-HPLC) was employed to determine the content of glycyrrhizic acid in different Gegenqinlian decoctions. RESULTS: Glycyrrhizic acid contents in the decoction of exclusive liquorice was 0.89%, and in Gegenqinlian decoctions composed of 2 or 3 ingredients, the acid contents varied from 0.24%, to 0.59%,. CONCLUSION: The presence of the constituents in Gegenqinlian decoction such as radices puerarire, radices scutellariae and coptis may significantly reduce the release of glycyrrhizic acid content from within liquorice into the decoction.


Subject(s)
Drugs, Chinese Herbal/chemistry , Glycyrrhizic Acid/analysis , Medicine, Chinese Traditional , Reference Standards
SELECTION OF CITATIONS
SEARCH DETAIL
...